QDIV - ETF AI Analysis
Top Page
Global X S&P 500 Quality Dividend ETF (QDIV)
QDIV, the Global X S&P 500 Quality Dividend ETF, appears to offer solid overall quality by focusing on financially strong, dividend-paying companies. Its rating is helped by standout holdings like Gilead Sciences, Accenture, and Cognizant, which show strong financial performance, favorable long-term outlooks, and strategic focus on growth areas such as AI and key drug portfolios. However, weaker names like IFF and Best Buy, which face profitability challenges, negative margins, or bearish technical signals, slightly weigh on the fund, and investors should note the risk that several holdings face valuation concerns or mixed technical trends.
QDIV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 31.51M
- Region
- North America
- Expense Ratio
- 0.20%
- Beta
- 0.48
- Issuer
- Global X
- Inception Date
- Jul 13, 2018
- Dividend Yield
- 2.61%
- Asset Class
- Equity
- Index Tracked
- S&P 500 Quality High Dividend Index
QDIV Summary
QDIV is the Global X S&P 500 Quality Dividend ETF, which follows the S&P 500 Quality High Dividend Index. It focuses on large, established U.S. companies that pay steady dividends and have strong finances. The fund holds well-known names like Accenture and Best Buy, along with firms in sectors such as technology, health care, and consumer defensive. Someone might invest in QDIV to seek a mix of regular income from dividends and long-term growth from solid companies. A key risk is that the ETF’s value can go up or down with the overall stock market, and dividend payments are not guaranteed.
How much will it cost me?
This ETF has an expense ratio of 0.20%, which means you’ll pay about $2 per year for every $1,000 you invest. That’s slightly below the average stock ETF fee, because it’s a passively managed fund that tracks an index rather than paying managers to pick individual stocks.
What would affect this ETF?
QDIV could benefit if the U.S. economy stays healthy, supporting large, established companies in sectors like consumer defensive, health care, and technology, and if interest rates stabilize or fall, making its dividend income more attractive compared with bonds. On the downside, higher interest rates, economic slowdowns, or sector-specific issues in financials, energy, or consumer cyclical stocks could pressure its holdings and reduce both dividend appeal and share prices.
QDIV Top 10 Holdings
QDIV leans heavily into U.S. large-cap dividend payers, with a noticeable tilt toward tech and health care names that are quietly doing the heavy lifting. Gilead Sciences and APA have been rising, giving the fund a boost from both defensive pharma and energy. Accenture and Cognizant, meanwhile, show more mixed signals, with recent volatility suggesting their momentum is losing a bit of steam. Becton Dickinson and Best Buy are steadier, helping smooth out bumps. Overall, it’s a U.S.-centric, quality-income story with no single stock dominating the stage.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 ACN | Accenture | 2.60% | $819.53K | $152.63B | 3.61% | 79Outperform |
 APA | APA | 2.43% | $766.11K | $18.51B | 135.80% | 73Outperform |
 BDX | Becton Dickinson | 2.42% | $761.43K | $53.90B | 10.31% | 67Neutral |
 GILD | Gilead Sciences | 2.46% | $773.40K | $211.64B | 44.11% | 78Outperform |
 BBY | Best Buy Co | 2.39% | $753.03K | $20.06B | 14.99% | 62Neutral |
 CTSH | Cognizant | 2.17% | $681.97K | $29.11B | -9.81% | 79Outperform |
 ADP | Automatic Data Processing | 2.22% | $699.75K | $116.43B | 12.35% | 70Outperform |
 IFF | International Flavors & Fragrances | 2.20% | $694.06K | $23.73B | 47.35% | 61Neutral |
 CDW | CDW | 2.29% | $722.09K | $19.23B | -1.92% | 62Neutral |
 FDS | Factset Research | 2.32% | $729.05K | $11.62B | 22.50% | 78Outperform |
QDIV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QDIV, the sentiment is Positive. The current price of 42.30 is above the 20-day moving average (MA) of 40.49, above the 50-day MA of 40.01, and above the 200-day MA of 37.84, indicating a bullish trend. The MACD of 0.76 indicates Negative momentum. The RSI at 68.74 is Neutral, neither overbought nor oversold. The STOCH value of 65.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QDIV.
QDIV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| QDIV | $42.31 | $43.00(1.64% Upside) | $31.51M | 0.20% | 71Outperform |
 PRMR | $28.30 | $34.39(21.51% Upside) | $93.63M | 1.00% | 73Outperform |
 SPXE | $80.85 | $100.63(24.47% Upside) | $86.64M | 0.09% | 74Outperform |
 FCUS | $36.61 | $47.35(29.34% Upside) | $86.02M | 0.80% | 67Neutral |
 NULC | $54.91 | $68.55(24.84% Upside) | $81.33M | 0.21% | 74Outperform |
 QARP | $68.79 | $80.14(16.49% Upside) | $79.50M | 0.19% | 73Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| QDIV | Global X S&P 500 Quality Dividend ETF | 42.30 | 9.12 | 27.49% | |
| PRMR | PeakShares RMR Prime Equity ETF | 28.30 | 3.32 | 13.31% | |
| SPXE | ProShares S&P 500 Ex-Energy ETF | 80.85 | 7.60 | 10.37% | |
| FCUS | Pinnacle Focused Opportunities ETF | 36.61 | 2.64 | 7.78% | |
| NULC | Nuveen ESG Large-Cap ETF | 54.91 | 7.00 | 14.61% | |
| QARP | Xtrackers Russell 1000 US Quality at a Reasonable Price ETF | 68.79 | 11.60 | 20.27% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.